{"id":"F2007B00704","name":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (12/03/2004)","slug":"therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62499,"registerId":"commonwealth-F2007B00704-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods Act 1989 - Order under subsection 3(1) – Definition of British Pharmacopoeia (12/03/2004)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\ntitle: Letterhead\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n \n\nTherapeutic Goods Act 1989\n\n \n\nORDER UNDER SUBSECTION 3(1) – DEFINITION OF BRITISH PHARMACOPOEIA\n\n \n\nI, TERRY SLATER, delegate of the Minister for Health and Ageing for the purposes of the exercise of the Minister’s powers under the definition of “British Pharmacopoeia” in subsection 3(1) of the Therapeutic Goods Act 1989 (“the Act”) and acting under that provision, HEREBY SPECIFY that on and from 1 April 2004 the definition of “British Pharmacopoeia” in the Act shall be the British Pharmacopoeia 2003.\n\n \n\n \n\nDated this       12th day of March 2004\n\n \n\n \n\n \n\n \n\n \n\n \n\nTERRY SLATER\n\nNational Manager\n\nTherapeutic Goods Administration\n\n(Delegate of the Minister for Health and Ageing)\n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2500},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This order performs exactly the narrow function intended by subsection 3(1) of the Act—specifying which edition of the British Pharmacopoeia applies. There has been no expansion beyond this simple definitional update."},"complexity_factors":["Single paragraph of operative text with no subsections or divisions","No schedules, tables, or attachments","No conditional logic, exceptions, or nested provisions","Straightforward administrative update of an external bibliographic reference"],"plain_english_summary":"**What this does:**\nThis order updates the legal meaning of the **British Pharmacopoeia** in the *Therapeutic Goods Act 1989*. The British Pharmacopoeia is an official book of quality standards for medicines (setting rules for how drugs should be made, tested, and what they should contain).\n\n**The change:**\nFrom **1 April 2004**, whenever the Act uses the term \"British Pharmacopoeia\", it legally refers to the **British Pharmacopoeia 2003** edition.\n\n**Who it affects:**\n* Pharmaceutical companies that must comply with these standards when making medicines for the Australian market\n* The Therapeutic Goods Administration (TGA) when assessing whether medicines meet quality requirements\n\n**Why it matters:**\nThis ensures Australian medicine laws keep pace with current international standards, so that drugs sold in Australia meet up-to-date safety and quality benchmarks."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004","history":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004/history","analysis":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004/analysis","conflicts":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004/conflicts","importantCases":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004/important-cases","documents":"/api/acts/therapeutic-goods-act-1989-order-under-subsection-3-1-definition-of-british-pharmacopoeia-12-03-2004/documents"}}